Hand-held fractional exhaled nitric oxide measurements as a non-invasive indicator of systemic inflammation in Crohn's disease

Journal of Crohn's and Colitis

Volumn 7, Issue 8, 2013, Pages 644-648

  Quenon, L ^a   Hindryckx, P ^a   De Vos, M ^a   De Looze, D ^a   Joos, G ^a   Brusselle, G ^a   Peeters, H ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Crohn's disease; Disease activity marker; Exhaled nitric oxide

Indexed keywords

BIOCHEMICAL MARKER; CALCIUM; CALGRANULIN; CORTICOSTEROID; FRACTIONAL EXHALED NITRIC OXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DISEASE ACTIVITY; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REMISSION; RESPIRATORY TRACT PARAMETERS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

(F)ENO; (FRACTIONAL) EXHALED NITRIC OXIDE; CROHN'S DISEASE; DISEASE ACTIVITY MARKER; EXHALED NITRIC OXIDE;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; BREATH TESTS; CASE-CONTROL STUDIES; CROHN DISEASE; FECES; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; NITRIC OXIDE; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX;

EID: 84880046873     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.09.021     Document Type: Article

References (21)

1. Kumar P.J., Clark M.L. Kumar & Clark's clinical medicine 2009, Saunders Elsevier, Edinburgh; New York. 7th ed.
2. Vermeire S., Van Assche G., Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys?. Gut 2006, 55:426-431.
3. Freeman H.J. Use of the Crohn's disease activity index in clinical trials of biological agents. World J Gastroenterol 2008, 14:4127-4130.
4. Yoshida E.M. The Crohn's disease activity index, its derivatives and the inflammatory bowel disease questionnaire: a review of instruments to assess Crohn's disease. Can J Gastroenterol 1999, 13:65-73.
5. Teixeira M., Ferguson A. Uses and limitations of the Crohn's Disease Activity Index. Arq Gastroenterol 1979, 16:67-72.
6. Gisbert J.P., McNicholl A.G. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Dig Liver Dis 2009, 41:56-66.
7. Garcia X., Stein F. Nitric oxide. Semin Pediatr Infect Dis 2006, 17:55-57.
8. Ljung T. Nitric oxide in inflammatory bowel disease 2003, Karolinska Institute, Stockholm.
9. Kolios G., Valatas V., Ward S.G. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 2004, 113:427-437.
10. Koek G.H., Verleden G.M., Evenepoel P., Rutgeerts P. Activity related increase of exhaled nitric oxide in Crohn's disease and ulcerative colitis: a manifestation of systemic involvement?. Respir Med 2002, 96:530-535.
11. Ozyilmaz E., Yildirim B., Erbas G., Akten S., Oguzulgen I.K., Tunc B., et al. Value of fractional exhaled nitric oxide (FENO) for the diagnosis of pulmonary involvement due to inflammatory bowel disease. Inflamm Bowel Dis 2010, 16:670-676.
12. Hemmingsson T., Linnarsson D., Gambert R. Novel hand-held device for exhaled nitric oxide-analysis in research and clinical applications. J Clin Monit Comput 2004, 18:379-387.
13. Ricciardolo F.L., Sterk P.J., Gaston B., Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004, 84:731-765.
14. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 2005, 171:912-930.
15. Mary J.Y., Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 1989, 30:983-989.
16. Jones J., Loftus E.V., Panaccione R., Chen L.S., Peterson S., McConnell J., et al. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease. Clin Gastroenterol Hepatol 2008, 6:1218-1224.
17. Herrlinger K.R., Noftz M.K., Dalhoff K., Ludwig D., Stange E.F., Fellermann K. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Am J Gastroenterol 2002, 97:377-381.
18. Van Praet L., Van den Bosch F., Mielants H., Elewaut D. Mucosal inflammation in spondylarthritides: past, present, and future. Curr Rheumatol Rep 2011, 13:409-415.
19. Louis E., Louis R., Shute J., Lau L., Franchimont D., Lamproye A., et al. Bronchial eosinophilic infiltration in Crohn's disease in the absence of pulmonary disease. Clin Exp Allergy 1999, 29:660-666.
20. Gladwin M.T. Role of the red blood cell in nitric oxide homeostasis and hypoxic vasodilation. Adv Exp Med Biol 2006, 588:189-205.
21. Kim-Shapiro D.B., Schechter A.N., Gladwin M.T. Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. Arterioscler Thromb Vasc Biol 2006, 26:697-705.